...
首页> 外文期刊>Chemical Weekly >India needs to step up to be a biopharma major: BCG
【24h】

India needs to step up to be a biopharma major: BCG

机译:印度需要加紧成为生物制药专业:BCG

获取原文
获取原文并翻译 | 示例
           

摘要

A study by Boston Consulting Group (BCG) has revealed that to become an innovation hub in biopharma sector, India has to improve its capabilities in information technology, engineering, and clinical research."India can become a global innovation hub, but there are several challenges to fully realising its potential, particularly around policy, infrastructure,and creating collaborative partnerships," said Mr. Kim Wagner, a BCG senior partner and co-author of the report.
机译:波士顿咨询集团(BCG)的一项研究表明,印度要成为生物制药领域的创新中心,就必须提高其在信息技术,工程和临床研究方面的能力。“印度可以成为全球创新中心,但是有几个充分发挥其潜力尤其是在政策,基础设施以及建立合作伙伴关系方面面临的挑战。” BCG高级合伙人,报告的合著者Kim Wagner先生说。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号